Last week, the New York Times published an article about a U.S. government complaint that Johnson & Johnson paid kickbacks to the biggest nursing home pharmacy in the U.S. to increase prescriptions of the antipsychotic Risperdal and other drugs. On her blog ElderCareTalk, Laura Bramly has posted a great analysis of what this means for people whose family members are in memory care units.
« From AA to AD, A Wistful Travelogue: Book Review | Main | MCI Symposium: Memory Loss and Exercise »
January 20, 2010
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451d58669e20120a7f1f4ad970b
Listed below are links to weblogs that reference Johnson & Johnson Risperdal Kickback Allegations:
The comments to this entry are closed.
Legal Stuff
- Inclusion of links, advertisements and content generated by others does not imply endorsement. Remember, nothing on this site is meant as a substitute for professional medical advice or for using your own judgment!
Comments